DE2403055A1 - Pharmazeutisch verwendbare mischungen oder salze auf der grundlage von basischen chinolin-verbindungen - Google Patents

Pharmazeutisch verwendbare mischungen oder salze auf der grundlage von basischen chinolin-verbindungen

Info

Publication number
DE2403055A1
DE2403055A1 DE2403055A DE2403055A DE2403055A1 DE 2403055 A1 DE2403055 A1 DE 2403055A1 DE 2403055 A DE2403055 A DE 2403055A DE 2403055 A DE2403055 A DE 2403055A DE 2403055 A1 DE2403055 A1 DE 2403055A1
Authority
DE
Germany
Prior art keywords
compound
formula
same meaning
alkyl
salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE2403055A
Other languages
German (de)
English (en)
Inventor
Thomas Brian Lee
Thomas Samuel Campbell Orr
Norman Harold Rogers
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fisons Ltd
Original Assignee
Fisons Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fisons Ltd filed Critical Fisons Ltd
Publication of DE2403055A1 publication Critical patent/DE2403055A1/de
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • C07D215/42—Nitrogen atoms attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • C07D215/42—Nitrogen atoms attached in position 4
    • C07D215/46—Nitrogen atoms attached in position 4 with hydrocarbon radicals, substituted by nitrogen atoms, attached to said nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/24—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78—Ring systems having three or more relevant rings
    • C07D311/80—Dibenzopyrans; Hydrogenated dibenzopyrans
    • C07D311/82—Xanthenes
    • C07D311/84—Xanthenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 9
    • C07D311/86—Oxygen atoms, e.g. xanthones

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Pyrane Compounds (AREA)
DE2403055A 1973-01-23 1974-01-23 Pharmazeutisch verwendbare mischungen oder salze auf der grundlage von basischen chinolin-verbindungen Pending DE2403055A1 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB335273 1973-01-23
GB1788673 1973-04-13
GB2182273 1973-05-08
GB4611673 1973-10-03
GB5420273 1973-11-22

Publications (1)

Publication Number Publication Date
DE2403055A1 true DE2403055A1 (de) 1974-07-25

Family

ID=27515722

Family Applications (1)

Application Number Title Priority Date Filing Date
DE2403055A Pending DE2403055A1 (de) 1973-01-23 1974-01-23 Pharmazeutisch verwendbare mischungen oder salze auf der grundlage von basischen chinolin-verbindungen

Country Status (5)

Country Link
JP (1) JPS49102826A (enrdf_load_stackoverflow)
DE (1) DE2403055A1 (enrdf_load_stackoverflow)
FR (1) FR2214480A1 (enrdf_load_stackoverflow)
IL (1) IL44022A0 (enrdf_load_stackoverflow)
NL (1) NL7400827A (enrdf_load_stackoverflow)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2703119A1 (de) * 1976-01-30 1977-08-04 Fisons Ltd Dinatriumcromoglycat mit weniger als 5 % wasser und dieses umfassende pharmazeutische praeparate
DE2831419A1 (de) * 1977-07-19 1979-02-01 Fisons Ltd Dispersion oder suspension aus lecithin oder einem sorbitan- oder sorbit-ester in treibmittel 12

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1582362A (en) * 1977-03-17 1981-01-07 Fisons Ltd Cromoglycic acid salts and compositions

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2703119A1 (de) * 1976-01-30 1977-08-04 Fisons Ltd Dinatriumcromoglycat mit weniger als 5 % wasser und dieses umfassende pharmazeutische praeparate
DE2831419A1 (de) * 1977-07-19 1979-02-01 Fisons Ltd Dispersion oder suspension aus lecithin oder einem sorbitan- oder sorbit-ester in treibmittel 12

Also Published As

Publication number Publication date
NL7400827A (enrdf_load_stackoverflow) 1974-07-25
FR2214480A1 (en) 1974-08-19
JPS49102826A (enrdf_load_stackoverflow) 1974-09-28
IL44022A0 (en) 1974-05-16

Similar Documents

Publication Publication Date Title
DE69107215T2 (de) (2-imidazolin-2-ylamino)chinoxalinderivate und methoden in ihrer anwendung.
DE2343657A1 (de) Neuer ester eines eckige klammer auf (methylamino)methyl eckige klammer zu benzyl-alkohols
DE2736784A1 (de) N-substituierte und nichtsubstituierte hexahydro-6-canthinonderivate, verfahren zum herstellen derselben und diese derivate enthaltende pharmazeutische zusammensetzung
DE69217511T2 (de) Pyridazindionderivate, ihre Herstellung und Verwendung als Arzneimittel
EP0038343B1 (de) Substituierte oxocarbonsäuren, verfahren zu ihrer herstellung, ihre verwendung und sie enthaltende arzneimittel
DE1518764C3 (de) In der 7-Stellung substituierte S-Phenyl-2-oxo-23-dihydro-lH-1 ^-benzodiazepin-S-carbonsäuresalze und -alkylester
DE2418344A1 (de) Derivate von 3-nitrocumarinen enthaltende arzneimittel, neue 3-nitrocumarine und verfahren zu ihrer herstellung
DE2802493A1 (de) Neue imidazochinoline und deren salze, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen
DE68907392T2 (de) Dysmnesie modifizierende Arzneimittel.
DE2403055A1 (de) Pharmazeutisch verwendbare mischungen oder salze auf der grundlage von basischen chinolin-verbindungen
DE2726793A1 (de) 2-imino-3-aminothiazolidine
DE2243997A1 (de) Tricyclische verbindungen, verfahren zu ihrer herstellung und ihre verwendung
DE2525249C2 (de) N,N'-(m-Phenylen)-dioxamsäuren und deren Derivate, Verfahren zur Herstellung derselben und dieselben enthaltende pharmazeutische Präparate
DE2448389A1 (de) Derivate von 4-hydroxy-3-nitro-alpha- pyridonen enthaltende arzneimittel, neue 4-hydroxy-3-nitro-alpha-pyridone und verfahren zu ihrer herstellung
EP0240874B1 (de) Hochresorbierbare Zubereitungsform des Hymecromons und Verfahren zur Herstellung derselben
DE2446497A1 (de) 4-oxo-4h-pyrano- eckige klammer auf 3,2-c eckige klammer zu -chinolin-2-carbonsaeuren und ihre salze
DE2264938A1 (de) 3-arylaminocarbonyl-4-hydroxy-benzo eckige klammer auf b eckige klammer zu thiacyclohex(3)en-1,1-dioxide, verfahren zu ihrer herstellung und diese enthaltende arzneimittel
DE69214205T2 (de) Neue Isatineoxime Derivate, ihre Herstellung und Verwendung
DE3415666A1 (de) Neue acylaminophenolderivate
EP0121856A2 (de) Verwendung von Pyrazolonderivaten bei der Bekämpfung des Wachstums von Tumorzellen und der Metastasenbildung, Arzneimittel hierfür und Verfahren zu deren Herstellung
DE2754148A1 (de) Substituierte aminoaethanole, verfahren zu ihrer herstellung und ihre verwendung als arzneistoffe
DE1695785A1 (de) Neue,substituierte 2-Aminomethylbenzofuranverbindungen und Verfahren zu deren Herstellung
DE2806879A1 (de) 4-hydroxy-2-chinolinon-3-carbonsaeure- esterderivate
DE1915023C3 (de) (2,4-Dlmethoxyphenyl)-3-Crotonsäure enthaltende Hellmittel für Gallen· und Lebererkrankungen
AT300797B (de) Verfahren zur Herstellung von neuen Benzodipyronen